A systematic review and meta-analysis of probiotics for the management of radiation induced bowel disease

Clinical Nutrition

Volumn 32, Issue 3, 2013, Pages 353-360

  Hamad, Adeel ^a,b   Fragkos, Konstantinos C ^a,b   Forbes, Alastair ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

Pelvic radiotherapy; Probiotics; Radiation induced bowel damage

Indexed keywords

CISPLATIN; LOPERAMIDE; PLACEBO; PROBIOTIC AGENT;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIARRHEA; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; GENETIC HETEROGENEITY; HUMAN; INCIDENCE; INTENTION TO TREAT ANALYSIS; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; OUTCOME ASSESSMENT; QUALITY CONTROL; RADIOTHERAPY; RANDOMIZED CONTROLLED TRIAL; UTERINE CERVIX CARCINOMA; UTERUS CARCINOMA;

DIARRHEA; DIETARY SUPPLEMENTS; HUMANS; INFLAMMATORY BOWEL DISEASES; PELVIS; PROBIOTICS; RADIATION INJURIES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 84877117670     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2013.02.004     Document Type: Article

References (43)

1. Walsh D. Deep tissue traumatism from Roentgen ray exposure. Br Med J 1897, 2:272-273.
2. Andreyev J. Gastrointestinal symptoms after pelvic radiotherapy: a new understanding to improve management of symptomatic patients. Lancet Oncol 2007, 8:1007-1017.
3. Andreyev H.J., Wotherspoon A., Denham J.W., Hauer-Jensen M. "Pelvic radiation disease": new understanding and new solutions for a new disease in the era of cancer survivorship. Scand J Gastroenterol 2011, 46:389-397.
4. Andreyev H.J. Gastrointestinal problems after pelvic radiotherapy: the past, the present and the future. Clin Oncol (R Coll Radiol) 2007, 19:790-799.
5. Denton A., Forbes A., Andreyev J., Maher E.J. Non surgical interventions for late radiation proctitis in patients who have received radical radiotherapy to the pelvis. Cochrane Database Syst Rev 2002, 1.
6. Abayomi J., Kirwan J., Hackett A. The prevalence of chronic radiation enteritis following radiotherapy for cervical or endometrial cancer and its impact on quality of life. Eur J Oncol Nurs 2009, 13:262-267.
7. Andreyev H.J., Vlavianos P., Blake P., Dearnaley D., Norman A.R., Tait D. Gastrointestinal symptoms after pelvic radiotherapy: role for the gastroenterologist?. Int J Radiat Oncol Biol Phys 2005, 62:1464-1471.
8. Gillespie C., Goode C., Hackett C., Andreyev H.J. The clinical needs of patients with chronic gastrointestinal symptoms after pelvic radiotherapy. Aliment Pharmacol Ther 2007, 26:555-563.
9. Zimmerer T., Bocker U., Wenz F., Singer M.V. Medical prevention and treatment of acute and chronic radiation induced enteritis - is there any proven therapy? a short review. Z Gastroenterol 2008, 46:441-448.
10. Henson C.C., Davidson S.E., Lalji A., Symonds R.P., Swindell R., Andreyev H.J. Gastrointestinal symptoms after pelvic radiotherapy: a national survey of gastroenterologists. Support Care Cancer 2012, 20:2129-2139.
11. McGough C., Baldwin C., Frost G., Andreyev H.J. Role of nutritional intervention in patients treated with radiotherapy for pelvic malignancy. Br J Cancer 2004, 90:2278-2287.
12. Hamer H.M., Jonkers D., Venema K., Vanhoutvin S., Troost F.J., Brummer R.J. Review article: the role of butyrate on colonic function. Aliment Pharmacol Ther 2008, 27:104-119.
13. Reid G., Sanders M.E., Gaskins H.R., Gibson G.R., Mercenier A., Rastall R., et al. New scientific paradigms for probiotics and prebiotics. J Clin Gastroenterol 2003, 37:105-118.
14. Guarner F., Perdigon G., Corthier G., Salminen S., Koletzko B., Morelli L. Should yoghurt cultures be considered probiotic?. Br J Nutr 2005, 93:783-786.
15. Hempel S., Newberry S.J., Maher A.R., Wang Z., Miles J.N., Shanman R., et al. Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis. J Am Med Assoc 2012, 307:1959-1969.
16. Moher D., Liberati A., Tetzlaff J., Altman D.G. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009, 151:264-269. W64.
17. Huedo-Medina T.B., Sanchez-Meca J., Marin-Martinez F., Botella J. Assessing heterogeneity in meta-analysis: Q statistic or I2 index?. Psychol Methods 2006, 11:193-206.
18. Higgins J.P., Thompson S.G. Quantifying heterogeneity in a meta-analysis. Stat Med 2002, 21:1539-1558.
19. Bowden J., Tierney J.F., Copas A.J., Burdett S. Quantifying, displaying and accounting for heterogeneity in the meta-analysis of RCTs using standard and generalised Q statistics. BMC Med Res Methodol 2011, 11:41.
20. Gueniche A., Benyacoub J., Buetler T.M., Smola H., Blum S. Supplementation with oral probiotic bacteria maintains cutaneous immune homeostasis after UV exposure. Eur J Dermatol 2006, 16:511-517.
21. Peguet-Navarro J., Dezutter-Dambuyant C., Buetler T., Leclaire J., Smola H., Blum S., et al. Supplementation with oral probiotic bacteria protects human cutaneous immune homeostasis after UV exposure-double blind, randomized, placebo controlled clinical trial. Eur J Dermatol 2008, 18:504-511.
22. Bouilly-Gauthier D., Jeannes C., Maubert Y., Duteil L., Queille-Roussel C., Piccardi N., et al. Clinical evidence of benefits of a dietary supplement containing probiotic and carotenoids on ultraviolet-induced skin damage. Br J Dermatol 2010, 163:536-543.
23. Weill F.S., Cela E.M., Paz M.L., Ferrari A., Leoni J., Gonzalez Maglio D.H. Lipoteichoic acid from Lactobacillus rhamnosus GG as an oral photoprotective agent against UV-induced carcinogenesis. Br J Nutr 2012, 1-10.
24. Smirnova, Filatova E.I., Suvorov A.N., Bylinskaia E.N. The use of therapeutic/prophylactic dragee "honey laminolact" in radiotherapy of uterine tumors. Vopr Onkol 2000, 46:748-750.
25. Urbancsek H., Kazar T., Mezes I., Neumann K. Results of a double-blind, randomized study to evaluate the efficacy and safety of antibiophilus in patients with radiation-induced diarrhoea. Eur J Gastroenterol Hepatol 2001, 13:391-396.
26. Delia P., Sansotta G., Donato V., Frosina P., Messina G., De Renzis C., et al. Use of probiotics for prevention of radiation-induced diarrhea. World J Gastroenterol 2007, 13:912-915.
27. Giralt J., Regadera J.P., Verges R., Romero J., de la Fuente I., Biete A., et al. Effects of probiotic Lactobacillus casei DN-114 001 in prevention of radiation-induced diarrhea: results from multicenter, randomized, placebo-controlled nutritional trial. Int J Radiat Oncol Biol Phys 2008, 71:1213-1219.
28. Chitapanarux I., Chitapanarux T., Traisathit P., Kudumpee S., Tharavichitkul E., Lorvidhaya V. Randomized controlled trial of live Lactobacillus acidophilus plus Bifidobacterium bifidum in prophylaxis of diarrhea during radiotherapy in cervical cancer patients. Radiat Oncol 2010, 5:31.
29. Timko J. Probiotics as prevention of radiation-induced diarrhoea. J Radiother Pract 2010, 9:201-208.
30. Salminen E., Elomaa I., Minkkinen J., Vapaatalo H., Salminen S. Preservation of intestinal integrity during radiotherapy using live Lactobacillus acidophilus cultures. Clin Radiol 1988, 39:435-437.
31. Okawa T., Niibe H., Arai T., Sekiba K., Noda K., Takeuchi S., et al. Effect of LC9018 combined with radiation therapy on carcinoma of the uterine cervix. A phase III, multicenter, randomized, controlled study. Cancer 1993, 72:1949-1954.
32. Henriksson R., Franzen L., Sandstrom K., Nordin A., Arevarn M., Grahn E. Effects of active addition of bacterial cultures in fermented milk to patients with chronic bowel discomfort following irradiation. Support Care Cancer 1995, 3:81-83.
33. Castro M.G., Sanchez P.X., Glasberg J., Horie L.M., Waitzberg D.L. Effects of probiotic in prevention of radiation-induced diarrhea. Clin Nutr Suppl 2009, 4:72-73.
34. Germain I., Desjardins J., Demers M., Dagnault A. Phase III study: impact of probiotics on diarrhea in patients treated with pelvic radiation. Int J Radiat Oncol Biol Phys 2011, 81:S667-S668.
35. Delia P., Sansotta G., Donato V., Messina G., Frosina P., Pergolizzi S., et al. Prophylaxis of diarrhoea in patients submitted to radiotherapeutic treatment on pelvic district: personal experience. Dig Liver Dis 2002, 34(Suppl. 2):S84-S86.
36. Delia P., Sansotta G., Donato V., Messina G., Frosina P., Pergolizzi S., et al. Prevention of radiation-induced diarrhea with the use of VSL#3, a new high-potency probiotic preparation. Am J Gastroenterol 2002, 97:2150-2152.
37. Delia P., Sansotta G., Donato V., Frosina P., Salatino A., Messina G., et al. Use of probiotics for prevention of radiation-induced diarrhea. Tumori 2007, 93(Suppl.):1-6.
38. Knapp G., Biggerstaff B.J., Hartung J. Assessing the amount of heterogeneity in random-effects meta-analysis. Biom J 2006, 48:271-285.
39. Lomax A.R., Calder P.C. Probiotics, immune function, infection and inflammation: a review of the evidence from studies conducted in humans. Curr Pharm Des 2009, 15:1428-1518.
40. Ciorba M.A., Riehl T.E., Rao M.S., Moon C., Ee X., Nava G.M., et al. Lactobacillus probiotic protects intestinal epithelium from radiation injury in a TLR-2/cyclo-oxygenase-2-dependent manner. Gut 2012, 61:829-838.
41. Seal M., Naito Y., Barreto R., Lorenzetti A., Safran P., Marotta F. Experimental radiotherapy-induced enteritis: a probiotic interventional study. J Dig Dis 2007, 8:143-147.
42. McCarthy J., O'Mahony L., O'Callaghan L., Sheil B., Vaughan E.E., Fitzsimons N., et al. Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance. Gut 2003, 52:975-980.
43. Dieleman L.A., Goerres M.S., Arends A., Sprengers D., Torrice C., Hoentjen F., et al. Lactobacillus GG prevents recurrence of colitis in HLA-B27 transgenic rats after antibiotic treatment. Gut 2003, 52:370-376.